Özlem TÜFEKÇİ, Dilek İNCE, Şefika AKYOL, Meral TORUN BAYRAM, Refik Emre ÇEÇEN, Ayşe ÇAKIL GÜZİN, Hatice KARAOĞLU ASRAK, İrem Ceren ERBAŞ, Şilem ÖZDEM ALATAŞ, Nurşen BELET

The clinical follow-up and management of COVID-19 in children and adolescents with an immunocompromised state or a malignancy

Background/aim: It is still not known how an immunosuppressive state affects the response to coronavirus disease 2019 (COVID-19) in children and adolescents. The aim of this study was to evaluate clinical characteristics, outcomes, and follow-up results of COVID-19 in pediatric patients with a history of immunocompromise or malignancy, retrospectively. Materials and methods: Patients with a diagnosis of COVID-19 who were under 18 years of age and had a history of immunosuppressive chronic disease or under immunosuppressant treatment were included in the study. Patients were applied to our outpatient clinic or consulted to our department in a tertiary center during the first year of the pandemic. Results: We evaluated 18 patients with a median age of 15.0 (0.6–17.8) years. Twelve patients (66.6%) were tested because of a symptom and the most common symptom was fever (44.4%, n = 8). Ten of the symptomatic patients (55.5% of all cohort) had a mild disease, the remaining two patients (11.1%) with an end-stage malignancy had critical diseases. Twelve patients (66.7%) were managed on an outpatient basis and were followed up at home, while the remaining six (33.3%) required hospitalization. One patient, who had Ewing sarcoma, died during the follow-up in the intensive care unit, and others were recovered without any morbidities. Lymphocyte (LYM) counts were significantly lower, C-reactive protein (CRP), and ferritin levels were higher in the individuals that needed hospitalization (p = 0.039, 0.027, and 0.039, respectively). Conclusion: Immunocompromised children and adolescents with COVID-19 should be monitored closely, especially those with an end-stage malignancy, low LYM count, or high CRP and ferritin levels.

PDF

___

1. Al-Qahtani AA. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): emergence, history, basic, and clinical aspects. Saudi Journal of Biological Sciences 2020; 27: 2531-2538. doi: 10.1016/j.sjbs.2020.04.033
2. Tezer H, Bedir Demirdağ T. Novel Coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences. 2020; 50 (SI-1): 592-603. doi: 10.3906/sag-2004-174 ERBAŞ et al. / Turk J Med Sci 578
3. Yayla BCC, Aykac K, Ozsurekci Y, Ceyhan M. Characteristics and management of children with COVID-19 in a tertiary care hospital in Turkey. Clinical Pediatrics 2021; 60 (3): 170-177. doi: 10.1177/0009922820966306
4. Lu X, Zhang L, Du H, Zhang J, Li YY et al. Chinese pediatric novel Coronavirus study team SARS-CoV-2 infection in children. The New England Journal of Medicine 2020; 382: 1663-1665. doi: 10.1056/NEJMc2005073
5. Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. Epidemiology of COVID-19 among children in China pediatrics 2020; 145: e20200702. doi: 10.1542/peds.2020-0702
6. Pathak EB, Salemi JL, Sobers N, Menard J, Hambleton IR. COVID-19 in children in the United States: intensive care admissions, estimated total infected, and projected numbers of severe pediatric cases in 2020. Journal of Public Health Management Practice 2020; 26: 325-333. doi: 10.1097/ PHH.0000000000001190
7. Abdulamir AS, Hafidh RR. The possible immunological pathways for the variable immunopathogenesis of COVID-19 infections among healthy adults, elderly and children. Electronic Journal of General Medicine 2020; 17: em202. doi:10.29333/ejgm/7850
8. Brodin P. Why is COVID-19 so mild in children? Acta Paediatrica 2020; 109: 1082-1083. doi: 10.1111/apa.15271
9. Kronbichler A, Gauckler P, Windpessl M, Il Shin J, Jha V et al. COVID-19: implications for immunosuppression in kidney disease and transplantation. Nature Reviews Nephrology 2020; 16: 365-367. doi: 10.1016/j.ekir.2020.10.023
10. D’Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transplantation 2020; 26: 832-834. doi: 10.1002/lt.25756
11. Radhakrishnan V, Ovett J, Rajendran A, Kolluru S, Pai V et al. COVID19 in children with cancer in low and middle income countries: experience from a cancer center in Chennai, India. Pediatric Hematology and Oncology 2020; 5: 1-7. doi: 10.1080/08880018.2020.1831113
12. Zhang L, Zhu F, Xie L, Wang C, Wang J et al. Clinical characteristics of COVID-19 infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of Oncology 2020; 31: 894-901. doi: 10.1016/j. annonc.2020.03.296
13. Liang W, Guan W, Chen R, Wang W, Li J et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology 2020; 21: 335-337. doi: 10.1016/S1470- 2045(20)30096-6
14. Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M et al. Case fatality rate of cancer patients with COVID-19 in a New York Hospital system. Cancer Discovery 2020; 10: 935-941. doi: 10.1158/2159-8290.CD-20-0516
15. Addeo A, Friedlaender A. Cancer, and COVID-19: Unmasking their ties. Cancer Treatment Reviews 2020; 88: 102041. doi: 10.1016/j.ctrv.2020.102041
16. Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H et al. SARSCoV-2 (COVID-19) in patients with some degree of immunosuppression. Reumatologia Clinica 2021; 17 (7): 408- 419. doi: 10.1016/j.reumae.2020.08.001
17. Minotti C, Tirelli F, Barbieri E, Giaquinto C, Donà D. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. Journal of Infection 2020; 81: e61-6. doi: 10.1016/j.jinf.2020.04.026
18. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2011; 52: 56- 93. doi: 10.1093/cid/cir073
19. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E et al. Acute respiratory distress syndrome: the Berlin definition. Journal of the American Medical Association 2012; 307: 2526-2533. doi: 10.1001/jama.2012.5669
20. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatric Critical Care Medicine 2020; 21: e52-106. doi: 10.1097/PCC.0000000000002198
21. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood 2011; 118: 4041-4052. doi: 10.1182/blood-2011-03-278127
22. Şık N, Özlü C, Karaoğlu Asrak H, Erbaş İC, Çakıl Güzin A et al. Evaluation of SARS-CoV-2 PCR positive cases in the pediatric emergency department. Mikrobiyoloji Bülteni 2020; 54: 629- 637. doi: 10.5578/mb.70086
23. Gampel B, Troullioud Lucas AG, Broglie L, Gartrell-Corrado RD, Lee MT et al. COVID-19 disease in New York City pediatric hematology and oncology patients. Pediatric Blood Cancer 2020; 67: e28420. doi: 10.1002/pbc.28420
24. Kebudi R, Kurucu N, Tuğcu D, Hacısalihoğlu Ş, Fışgın T et al. COVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: a nationwide study. Pediatr Blood Cancer. 2021; 68: e28915. doi: 10.1002/pbc.28915
25. Balduzzi A, Brivio E, Rovelli A, Rizzari C, Gasperini S et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati. Bone Marrow Transplantation 2020; 55: 1900-1905. doi: 10.1038/s41409-020-0895-4
26. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. European Journal of Cancer 2020; 132: 11-16. doi: 10.1016/j. ejca.2020.03.021
27. De Rojas T, Pérez-Martínez A, Cela E, Baragaño M, Galán V et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatric Blood Cancer 2020; 67: e28397. doi: 10.1002/pbc.28397
28. Chen Z, Xiong H, Li JX, Li H, Tao F et al. COVID-19 with postchemotherapy agranulocytosis in childhood acute leukemia: a case report. Zhonghua Xue Ye Xue Za Zhi 2020; 41: 341-343. doi: 10.3760/cma.j.issn.0253-2727.2020.0004
29. Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A et al. SARS-COV-2 infection in children and newborns: a systematic review. European Journal of Pediatrics 2020; 179: 1029-1046. doi: 10.1007/s00431-020-03684-7
30. Ferrari A, Zecca M, Rizzari C, Porta F, Provenzi M et al. Children with cancer in the time of COVID-19: an 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatric Blood Cancer 2020; 67: e28410. doi: 10.1002/pbc.28410
31. Kebudi R, Chantada G, Kurucu N, Tuğcu D, Mukkada S et al. COVID-19: consequences for children with cancer in Turkey and globally. Turkish Archives of Pediatrics 2021; 56: 295-299. doi: 10.5152/TurkArchPediatr.2021.21134
32. Banerjee D, Popoola J, Shah S, Ster IC, Quan V et al. COVID-19 infection in kidney transplant recipients. Kidney International 2020; 97: 1076-1082. doi: 10.1016/j.kint.2020.03.018
33. Gandolfini I, Delsante M, Fiaccadori E, Zaza G, Manenti L et al. COVID-19 in kidney transplant recipients. American Journal of Transplantation 2020; 20 (7): 1941-1943. doi: 10.1111/ ajt.15891
34. Huang J, Lin H, Wu Y, Fang Y, Kumar R et al. COVID-19 in posttransplant patients-report of 2 cases. American Journal of Transplantation 2020; 20: 1879-1881. doi: 0.1111/ajt.15896
35. Ning L, Liu L, Li W, Liu H, Wang J et al. Novel Coronavirus (SARS-CoV-2) infection in a renal transplant recipient: case report. American Journal of Transplantation 2020; 20: 1864- 1868. doi: 10.1111/ajt.15897
36. Angeletti A, Trivelli A, Magnasco A, Drovandi S, Sanguineri F et al. Risk of COVID-19 in young kidney transplant recipients results from a single-center observational study. Clinical Transplantation 2020; 34: e13889. doi: 10.1111/ctr.13889
37. Bush R, Johns F, Acharya R, Upadhyay K. Mild COVID-19 in a pediatric renal transplant recipient. American Journal of Transplantation 2020; 20: 2942-2945. doi: 10.1111/ajt.16003